Literature DB >> 10963720

Mechanisms of the pro- and anti-oxidant actions of nitric oxide in atherosclerosis.

R P Patel1, A Levonen, J H Crawford, V M Darley-Usmar.   

Abstract

The association of nitric oxide (NO) with cardiovascular disease has long been recognized and the extensive research on this topic has revealed both pro- and anti-atherosclerotic effects. While these contradictory findings were initially perplexing recent studies offer molecular mechanisms for the integration of these data in the context of our current understanding of the biochemistry of NO. The essential findings are that the biochemical properties of NO allow its exploitation as both a cell signaling molecule, through its interaction with redox centers in heme proteins, and an extremely rapid reaction with other biologically relevant free radicals. The direct reaction of NO with free radicals can have either pro- or antioxidant effects. In the cell, antioxidant properties of NO can be greatly amplified by the activation of signal transduction pathways that lead to the increased synthesis of endogenous antioxidants or down regulate responses to pro-inflammatory stimuli. These findings will be discussed in the context of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10963720     DOI: 10.1016/s0008-6363(00)00086-9

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  20 in total

Review 1.  The association between systemic sclerosis, arginine and asymmetric dimethylarginine.

Authors:  Li Zhang; Ya-Nan Wan; Jiu-Hua Zhao; Yu-Jie Wang; Ying-Xin Wang; Jun-Wei Yan; Xiao-Lei Huang; Jing Wang
Journal:  Inflammation       Date:  2015-02       Impact factor: 4.092

2.  Sustained nitric oxide (NO)-releasing compound reverses dysregulated NO signal transduction in priapism.

Authors:  Gwen Lagoda; Sena F Sezen; K Joseph Hurt; Marcelo R Cabrini; Dillip K Mohanty; Arthur L Burnett
Journal:  FASEB J       Date:  2013-09-27       Impact factor: 5.191

3.  Outer-sphere oxidation of Fe(II) in nitrosylmyoglobin by ferricyanide.

Authors:  Jens K S Møller; Leif H Skibsted
Journal:  J Biol Inorg Chem       Date:  2014-02-13       Impact factor: 3.358

4.  Nitric oxide acts as an antioxidant and delays programmed cell death in barley aleurone layers.

Authors:  Maria Veronica Beligni; Angelika Fath; Paul C Bethke; Lorenzo Lamattina; Russell L Jones
Journal:  Plant Physiol       Date:  2002-08       Impact factor: 8.340

5.  Correlation and Identification of Variable number of Tandem repeats of eNOS Gene in Coronary artery disease (CAD).

Authors:  Rabbani Syed; Moin Uddin Biyabani; Shiva Prasad; Farha Deeba; Kaiser Jamil
Journal:  Saudi J Biol Sci       Date:  2010-04-13       Impact factor: 4.219

6.  Lipid metabolism in rats is modified by nitric oxide availability through a Ca++-dependent mechanism.

Authors:  Carlos A Marra; Julio Nella; Damián Manti; María J T de Alaniz
Journal:  Lipids       Date:  2007-01-19       Impact factor: 1.880

7.  Endothelial glutathione-S-transferase A4-4 protects against oxidative stress and modulates iNOS expression through NF-kappaB translocation.

Authors:  Yongzhen Yang; Yusong Yang; Ya Xu; Scott D Lick; Yogesh C Awasthi; Paul J Boor
Journal:  Toxicol Appl Pharmacol       Date:  2008-04-07       Impact factor: 4.219

8.  Pathogenesis of atherosclerosis: A multifactorial process.

Authors:  Raja B Singh; Sushma A Mengi; Yan-Jun Xu; Amarjit S Arneja; Naranjan S Dhalla
Journal:  Exp Clin Cardiol       Date:  2002

9.  Lysophosphatidylcholine and 7-oxocholesterol modulate Ca2+ signals and inhibit the phosphorylation of endothelial NO synthase and cytosolic phospholipase A2.

Authors:  Elisabeth Millanvoye-Van Brussel; Gökce Topal; Annie Brunet; Thuc Do Pham; Valérie Deckert; Francine Rendu; Monique David-Dufilho
Journal:  Biochem J       Date:  2004-06-01       Impact factor: 3.857

Review 10.  Age-related changes in redox signaling and VSMC function.

Authors:  Muyao Li; Naomi K Fukagawa
Journal:  Antioxid Redox Signal       Date:  2010-03-01       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.